ESLA insider transaction filings
Estrella Immunopharma, Inc. — 5 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-26. Screen ESLA transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 2 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 4.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Liu Cheng — CEO, Director | 1 | — | — | 2 |
| Xu Jiandong — Chief Financial Officer | 1 | — | — | 2 |
Recent Form 4 filings — Estrella Immunopharma, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-26 | 4 | Liu Cheng — CEO, Director | Option exercise (M): 100,000 @ $0.81 · Option exercise (M): 100,000 (derivative) @ $0 | EDGAR |
| 2026-08-25 | 4 | Xu Jiandong — Chief Financial Officer | Option exercise (M): 100,000 @ $0.81 · Option exercise (M): 100,000 (derivative) | EDGAR |
| 2026-04-29 | 4 | Xu Jiandong — Chief Financial Officer | Purchase (P): 100 @ $1.04 · Purchase (P): 1,000 @ $1.16 · Purchase (P): 1,000 @ $1.33 | EDGAR |
| 2025-02-14 | 4 | Liu Cheng — Chief Executive Officer, Director | Grant/award (A): 490,796 (derivative) · Grant/award (A): 509,204 (derivative) | EDGAR |
| 2025-02-14 | 4 | Xu Jiandong — Chief Financial Officer | Grant/award (A): 490,796 (derivative) · Grant/award (A): 509,204 (derivative) | EDGAR |
Recent 8-K events — Estrella Immunopharma, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-08 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2026-08-21 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2026-06-30 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-01-13 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2026-01-06 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-04 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-06 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-09-29 | 8-K | 8.01 — Other Events | EDGAR |
| 2025-09-26 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2025-08-07 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ESLA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →